Funding Rounds
Anjarium Biosciences Series A (2021, $59M)
Anjarium BiosciencesAnjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.
Summary
Stage: Series A
Raised Amount: $59.53M
Raised Date: 2021-01-01
